Antisense oligonucleotides provide optimism to the therapeutic landscape for tauopathies

被引：0
|
作者：
Glenn A.Harris [1 ]
Lauren R.Hirschfeld [1 ]
机构：
[1] Rainwater Charitable Foundation
来源：
NeuralRegenerationResearch | 2025年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R741 [神经病学];
学科分类号：
摘要：
Tauopathies are a group of neurodegenerative diseases characterized by abnormal metabolism of the misfolded tau protein. Tau is encoded by the microtubule-associated protein tau gene(MAPT) and can be classified as either 3-repeat(3R) or 4-repeat(4R) based on the number of repeat domains from alternative splicing of exon 10 of the MAPT gene.
引用
收藏
页码：803 / 804
页数：2
相关论文
共 50 条
  • [1] Antisense oligonucleotides provide optimism to the therapeutic landscape for tauopathies
    Harris, Glenn A.
    Hirschfeld, Lauren R.
    NEURAL REGENERATION RESEARCH, 2025, 20 (03) : 803 - 804
  • [2] Antisense oligonucleotides might change the therapeutic landscape for Huntington's disease
    Paulsen, Jane S.
    Coffey, Christopher S.
    LANCET NEUROLOGY, 2019, 18 (10): : 911 - 912
  • [3] Antisense oligonucleotides as therapeutic agents
    Alama, A
    Barbieri, F
    Cagnoli, M
    Schettini, G
    PHARMACOLOGICAL RESEARCH, 1997, 36 (03) : 171 - 178
  • [4] THE THERAPEUTIC POTENTIAL OF ANTISENSE OLIGONUCLEOTIDES
    SHARMA, HW
    NARAYANAN, R
    BIOESSAYS, 1995, 17 (12) : 1055 - 1063
  • [5] Antisense oligonucleotides as therapeutic agents
    Galderisi, U
    Cascino, A
    Giordano, A
    JOURNAL OF CELLULAR PHYSIOLOGY, 1999, 181 (02) : 251 - 257
  • [6] THERAPEUTIC IMPLICATIONS OF ANTISENSE OLIGONUCLEOTIDES
    LATTUADA, D
    MAZZEI, M
    MEAZZA, R
    NICOLIN, A
    INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1992, 21 (04): : 296 - 299
  • [7] The therapeutic landscape of tauopathies: challenges and prospects
    Cummings, Jeffrey L.
    Gonzalez, M. Isabel
    Pritchard, Martyn C.
    May, Patrick C.
    Toledo-Sherman, Leticia M.
    Harris, Glenn A.
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [8] The therapeutic landscape of tauopathies: challenges and prospects
    Jeffrey L. Cummings
    M. Isabel Gonzalez
    Martyn C. Pritchard
    Patrick C. May
    Leticia M. Toledo-Sherman
    Glenn A. Harris
    Alzheimer's Research & Therapy, 15
  • [9] Therapeutic Antisense Oligonucleotides Are Coming of Age
    Bennett, C. Frank
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 307 - 321
  • [10] ANTISENSE OLIGONUCLEOTIDES - A NEW THERAPEUTIC PRINCIPLE
    UHLMANN, E
    PEYMAN, A
    CHEMICAL REVIEWS, 1990, 90 (04) : 543 - 584
12345